Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D Occhini
Allogeneic Hemopoietic Stem Cell Transplants for Patients With Relapsed Acute Leukemia: Long-Term Outcome
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood
Bone Marrow Transplantation
Transplantation
Hematology
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Disease Progression Is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcome After Intensive Reinduction Therapy and Allogeneic Stem Cell Transplant in Paediatric Relapsed Acute Myeloid Leukaemia
British Journal of Haematology
Hematology
Nilotinib Restores Long-Term Full-Donor Chimerism in Ph-Positive Acute Lymphoblastic Leukemia Relapsed After Allogeneic Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
Leukemia Research
Cancer Research
Oncology
Hematology
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
